Omnicuris Logo
HealthQuad Invests in LifeSigns AI Monitoring Platform

HealthQuad Invests in LifeSigns AI Monitoring Platform

Read More
Full Text
Yesterday

HealthQuad Invests in LifeSigns AI Monitoring Platform


HealthQuad recently announced a strategic investment in LifeSigns, an innovative AI patient monitoring platform. Specifically, this funding will help the Chennai-based startup expand its international footprint. Consequently, healthcare providers can detect early signs of patient deterioration much faster. LifeSigns integrates medical-grade wearables with a predictive AI engine to improve safety.


Clinical Impact of AI Patient Monitoring


For instance, it monitors heart rate, respiration, temperature, blood pressure, and oxygen saturation. Moreover, the system has already served over 325,000 patients across 50 facilities. This technology remarkably reduces code blue incidents by 90 per cent. Additionally, it lowers ICU readmissions by nearly 78 per cent. Clinicians can monitor data remotely through a cloud-based dashboard.


Expansion and Future Technology


Therefore, clinicians can intervene earlier than ever before to save lives. Furthermore, the company plans to enter Southeast Asia and the GCC region soon. However, the exact investment amount remains undisclosed by the group. This model is globally relevant for the next wave of healthcare technology. Selective integrations will soon strengthen the existing technology stack for better hospital efficiency.


Frequently Asked Questions


Q1: What specific vitals does the LifeSigns platform monitor?


The platform tracks heart rate, respiration, temperature, blood pressure, and oxygen saturation using medical-grade wearables.


Q2: How does the AI engine improve hospital safety?


It provides safety alerts by flagging early signs of clinical deterioration, which has reduced code blue incidents by 90 per cent.


Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.


References



  1. Quadria-arm to back patient monitoring platform LifeSigns - ETHealthworld

  2. HealthQuad Investment Portfolio and AI Healthcare Trends

  3. FDA Standards for Continuous Patient Monitoring Systems

Login to continue

More from MedShots Daily

HealthQuad Invests in LifeSigns AI Monitoring Platform
HealthQuad Invests in LifeSigns AI Monitoring Platform

HealthQuad invests in LifeSigns, an AI-driven patient monitoring platform that reduces ICU readmissions by 78% and improves clinical outcomes globally....

Yesterday

Read More
Full Text
Hantavirus Outbreak: Hospital Breach and Global Response
Hantavirus Outbreak: Hospital Breach and Global Response

Dutch hospital quarantines 12 staff after a hantavirus protocol breach. WHO reports nine cases in the Hondius outbreak; more cases are expected shortly....

Today

Read More
Full Text
Understanding Renal Cell Carcinoma Risk in Fumarate Hydratase Gene Variants
Understanding Renal Cell Carcinoma Risk in Fumarate Hydratase Gene Variants

This study clarifies RCC risk in FH-TPS-HLRCC patients, finding it lower (7.3%) than previous estimates, though adult surveillance remains essential....

Today

Read More
Full Text
HeartMate III vs. BrioVAD: A Comparative Study of Device-Induced Blood Damage
HeartMate III vs. BrioVAD: A Comparative Study of Device-Induced Blood Damage

An in vitro study finds that the HeartMate III and BrioVAD pumps show similar blood damage profiles, causing minimal hemolysis but impacting VWF and neutrop...

Today

Read More
Full Text
Dysregulation of the Ubiquitin-Proteasome System in Aging Muscle
Dysregulation of the Ubiquitin-Proteasome System in Aging Muscle

This article examines how the multi-layered dysregulation of the ubiquitin-proteasome system (UPS) drives sarcopenia by disrupting muscle protein homeostasi...

Today

Read More
Full Text
Multimodal AI Predicts End-Stage Renal Disease Years Before Symptoms
Multimodal AI Predicts End-Stage Renal Disease Years Before Symptoms

Researchers used MRI and genomic data from the UK Biobank to predict 5-year ESRD risk in healthy patients, identifying the rs1383063 SNP as a key factor....

Today

Read More
Full Text
Showing Page 1 of 1(5 items total)
Go to Page

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris